WallStreetZenWallStreetZen

NASDAQ: AARD
Aardvark Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aardvark Therapeutics earnings were -$69.9M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest AARD earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$21.6M, up 22.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AARD reported annual earnings of -$57.6M, with 179.7% growth. The next AARD earnings date is Aug 12, 2026.

AARD earnings history

Current Revenue
$0.0
Current Earnings
-$69.9M
Current Profit Margin
0%

AARD Return on Equity

Current Company
-61.7%
Current Industry
-141.9%
Current Market
13.5%
AARD's Return on Equity (-61.7%)... subscribe to Premium to read more.
High Return on Equity Performance

AARD Return on Assets

Current Company
-56.3%
Current Industry
-13.7%
AARD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AARD announces earnings.

AARD Return on Capital Employed

Current Company
-80.32%
Current Industry
-9.6%

AARD vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AARD-$69.47M-$69.87MN/A-$3.21
CRBU-$128.97M-$133.22MN/A-$1.42
HUMA-$79.74M-$97.59MN/A-$0.59
INDP-$18.86M-$18.86MN/A-$15.40
ENTX-$12.38M-$12.38MN/A-$0.27
View Top Biotech Stocks

AARD earnings dates

Next earnings date
Aug 12, 2026

Aardvark Therapeutics Earnings Reports & History FAQ

What were Aardvark Therapeutics's earnings last quarter?

On AARD's earnings call on Apr 6, 2026, Aardvark Therapeutics (NASDAQ: AARD) reported Q1 2026 earnings per share (EPS) of -$0.99, up 39.44% year over year. Total AARD earnings for the quarter were -$21.59 million. In the same quarter last year, Aardvark Therapeutics's earnings per share (EPS) was -$0.71.

If you're new to stock investing, here's how to buy Aardvark Therapeutics stock.

When does Aardvark Therapeutics report earnings?

The next AARD earnings date is Aug 12, 2026. Add AARD to your watchlist to be reminded of Aardvark Therapeutics's next earnings date.

Is Aardvark Therapeutics profitable or losing money?

As of the last Aardvark Therapeutics earnings report, Aardvark Therapeutics is currently losing money. Aardvark Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$69.87 million, a 152.05% increase year over year.

What was AARD's earnings growth in the past year?

As of Aardvark Therapeutics's earnings date in Apr 6, 2026, Aardvark Therapeutics's earnings has grown year over year. AARD earnings in the past year totalled -$69.87 million.

What are Aardvark Therapeutics's earnings expectations?

The current EPS estimate for Aardvark Therapeutics's earnings report in Aug 12, 2026 is -$0.87.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.